This may improve the accuracy of the test, particularly for mild TBI cases or regarding the diagnosis of sports-related concussion, where clinically important GFAP elevations are seen below the current detection threshold of the test (Reyes et al. 2023; Papa et al. 2024; O’Brien et al. 2025). This evidence concerns the gene GFAP and brain injury.